User profiles for L. W. Ellisen

Leif W. Ellisen

Professor of Medicine, Harvard Medical School
Verified email at mgh.harvard.edu
Cited by 27854

[HTML][HTML] The molecular pathogenesis of head and neck squamous cell carcinoma

SM Rothenberg, LW Ellisen - The Journal of clinical …, 2012 - Am Soc Clin Investig
… Lori Wirth and members of the Ellisen laboratory for helpful discussions and review of the
manuscript. This work was supported by NIH R01 DE-015945 (to LW Ellisen) and by NIH K08 …

p63 and p73 in human cancer: defining the network

MP Deyoung, LW Ellisen - Oncogene, 2007 - nature.com
The p53-related genes p63 and p73 exhibit significant structural homology to p53; however,
they do not function as classical tumor suppressors and are rarely mutated in human …

Neoadjuvant endocrine therapy for estrogen receptor–positive breast cancer: a systematic review and meta-analysis

…, A Gupta, KL Reynolds, MA Gadd, LW Ellisen… - JAMA …, 2016 - jamanetwork.com
Importance Estrogen receptor–positive (ER+) tumors of the breast are generally highly
responsive to endocrine treatment. Although endocrine therapy is the mainstay of adjuvant …

[HTML][HTML] hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization

M Meyerson, CM Counter, EN Eaton, LW Ellisen… - cell, 1997 - cell.com
Telomerase, the ribonucleoprotein enzyme that elongates telomeres, is repressed in normal
human somatic cells but is reactivated during tumor progression. We report the cloning of a …

TAN-1, the human homolog of the Drosophila notch gene, is broken by chromosomal translocations in T lymphoblastic neoplasms

LW Ellisen, J Bird, DC West, AL Soreng, TC Reynolds… - Cell, 1991 - cell.com
Previously we described joining of DNA in the 9 T cell receptor gene to DNA of an
uncharacterized locus in at (7; 9)(q34; q34. 3) chromosomal translocation from a case of human T …

Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1/TSC2 tumor suppressor complex

…, E Hafen, LA Witters, LW Ellisen… - Genes & …, 2004 - genesdev.cshlp.org
… Lei and LW Ellisen, in prep.). In contrast to Redd1 +/+ MEFs, Redd1 -/- MEFs failed to down-…
Both Redd1 and Redd2 are expressed during development (Ellisen et al. 2002). However, …

[HTML][HTML] Efficacy of neoadjuvant Cisplatin in triple-negative breast cancer

…, A Miron, C Colin, DC Sgroi, LW Ellisen… - Journal of clinical …, 2010 - ncbi.nlm.nih.gov
Purpose Cisplatin is a chemotherapeutic agent not used routinely for breast cancer treatment.
As a DNA cross-linking agent, cisplatin may be effective treatment for hereditary BRCA1-…

[HTML][HTML] The histone deacetylase Sirt6 regulates glucose homeostasis via Hif1α

…, Y Dor, R Weissleder, OS Shirihai, LW Ellisen… - Cell, 2010 - cell.com
SIRT6 is a member of a highly conserved family of NAD + -dependent deacetylases with
various roles in metabolism, stress resistance, and life span. SIRT6-deficient mice develop …

Hypoxia regulates TSC1/2–mTOR signaling and tumor suppression through REDD1-mediated 14–3–3 shuttling

…, P Horak, A Sofer, D Sgroi, LW Ellisen - Genes & …, 2008 - genesdev.cshlp.org
Hypoxia induces rapid and dramatic changes in cellular metabolism, in part through inhibition
of target of rapamycin (TOR) kinase complex 1 (TORC1) activity. Genetic studies have …

Frequent Mutation of Isocitrate Dehydrogenase (IDH)1 and IDH2 in Cholangiocarcinoma Identified Through Broad-Based Tumor Genotyping

…, V Deshpande, D Dias-Santagata, LW Ellisen… - The …, 2012 - academic.oup.com
Cancers of origin in the gallbladder and bile ducts are rarely curable with current modalities
of cancer treatment. Our clinical application of broad-based mutational profiling for patients …